Publisher： Bentham Science Publishers
E-ISSN： 2212-3873|18|2|98-109
ISSN： 1871-5303
Source： Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol.18, Iss.2, 2018-02, pp. : 98-109
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Economic Burden of Psoriatic Arthritis
By Ackermann Christoph Kavanaugh Arthur
PharmacoEconomics, Vol. 26, Iss. 2, 2008-01 ,pp. :
Access to resources
Recommend
An update on methotrexate pharmacogenetics in rheumatoid arthritis
Pharmacogenomics, Vol. 9, Iss. 4, 2008-04 ,pp. :
Clinical safety of tocilizumab in rheumatoid arthritis
By Bannwarth Bernard Richez Christophe
Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. :